INTEGRATED PLATFORM FOR RESEARCH AND DEVELOPMENT OF INNOVATIVE MEDICINES FOR CANCER AND METAPBOLICHE (Q2177181): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in es, and other parts: Adding Spanish translations) |
(Removed claims) |
||||||
| Property / EU contribution | |||||||
| |||||||
| Property / EU contribution: 466,511.11 Euro / rank | |||||||
| Property / budget | |||||||
| |||||||
| Property / budget: 933,022.21 Euro / rank | |||||||
| Property / co-financing rate | |||||||
| |||||||
| Property / co-financing rate: 50.0 percent / rank | |||||||
Revision as of 06:12, 9 February 2022
Project Q2177181 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | INTEGRATED PLATFORM FOR RESEARCH AND DEVELOPMENT OF INNOVATIVE MEDICINES FOR CANCER AND METAPBOLICHE |
Project Q2177181 in Italy |
Statements
7 November 2016
0 references
31 December 2019
0 references
TES PHARMA S.R.L.
0 references
43°7'44.51"N, 12°17'15.79"E
0 references
PIATTAFORMA INTEGRATA PER LA RICERCA E LO SVILUPPO DI FARMACI INNOVATIVI PER MALATTIE ONCOLOGICHE E METABOLICHE - SETUP DI NUOVI SAGGI BIOCHIMICI E CELLULARI AD-HOC (Italian)
0 references
INTEGRATED PLATFORM FOR RESEARCH AND DEVELOPMENT OF INNOVATIVE MEDICINES FOR CANCER AND METABOLIC DISEASES — SETUP OF NEW BIOCHEMICAL AND AD-HOC BIOASSAYS (English)
0 references
PLATEFORME INTÉGRÉE POUR LA RECHERCHE ET LE DÉVELOPPEMENT DE MÉDICAMENTS INNOVANTS POUR LE CANCER ET LES MALADIES MÉTABOLIQUES — MISE EN PLACE DE NOUVEAUX TESTS BIOCHIMIQUES ET CELLULAIRES AD HOC (French)
23 December 2021
0 references
GEÏNTEGREERD PLATFORM VOOR ONDERZOEK EN ONTWIKKELING VAN INNOVATIEVE GENEESMIDDELEN VOOR KANKER EN METABOLE ZIEKTEN — OPSTELLING VAN NIEUWE AD HOC BIOCHEMISCHE EN CELTESTS (Dutch)
24 December 2021
0 references
INTEGRIERTE PLATTFORM FÜR DIE ERFORSCHUNG UND ENTWICKLUNG INNOVATIVER MEDIKAMENTE FÜR KREBS- UND STOFFWECHSELKRANKHEITEN – AUFBAU NEUER AD-HOC-BIOCHEMIE- UND ZELLTESTS (German)
25 December 2021
0 references
PLATAFORMA INTEGRADA PARA LA INVESTIGACIÓN Y EL DESARROLLO DE FÁRMACOS INNOVADORES PARA EL CÁNCER Y LAS ENFERMEDADES METABÓLICAS: CONFIGURACIÓN DE NUEVAS PRUEBAS BIOQUÍMICAS Y CELULARES AD HOC (Spanish)
25 January 2022
0 references
Identifiers
I38I16000160007
0 references